BIOINFORMATICS

Genomic pipelines a clinician can sign, and an auditor can replay.

Secondary analysis, variant interpretation and multi-omics workflows built as containerised, version-pinned pipelines with a full provenance trail, aligned to NABL workflows and ABDM-FHIR, with patient data handled under the DPDP Act. We are building a clinical genomics platform of our own on the same pipelines.

Certified·ISO/IEC 27001·ISO 9001·ISO/IEC 20000·ISO/IEC 42001·Startup India·MSME

4 active engagements·India and the UK·See them

How it works

How a sample becomes a signed report: seven stages, two of which can stop it.

From raw reads through quality control, alignment and variant calling under GATK Best Practices, annotation against pinned databases, ACMG/AMP classification with clinician sign-off, a tiered FHIR-exportable report, and a full provenance record.

Metagenomics, isolate genomics and RNA-Seq run their own rails with the same discipline: QC before compute, pinned references, a review gate, and a provenance record that lets any run be replayed. That is what an accreditation assessor asks for, and what the validation report is written against.

  1. Reads (Intake). Raw reads from Illumina, MGI or Oxford Nanopore, checksummed on arrival and registered against the sample. Tools: FASTQ, Checksums, Sample manifest.
  2. QC (Quality control). Read quality, contamination and coverage checked before any compute is spent on the sample. Tools: FastQC or equivalent, Coverage thresholds per assay. Gate: A sample below the coverage threshold stops here.
  3. Align and call (Secondary analysis). Alignment and variant calling under GATK Best Practices, GPU-accelerated where the science permits. Tools: GATK, NVIDIA Parabricks, AWS Batch, Azure Batch or Cloud Batch.
  4. Annotate (Annotation). Variants annotated against pinned reference and database versions, recorded per run so the annotation can be reproduced. Tools: ClinVar, Pinned reference genome, Version-pinned databases.
  5. Classify (Interpretation). Evidence assembled per variant into a draft ACMG/AMP classification for a clinician to review. Tools: ACMG/AMP criteria, Evidence per variant. Gate: A clinician signs before a report exists.
  6. Report (Clinical output). A tiered clinical report aligned to NABL workflows, exportable as FHIR for ABDM interoperability. Tools: Tiered report, FHIR resources.
  7. Provenance (Audit). Every tool version, reference, parameter and decision recorded, so the run can be replayed and the report defended. Tools: Nextflow, Docker, Tamper-evident audit trail.

What we build

Six things we build, and the standards each one follows.

  • Whole-exome secondary analysis

    From raw reads to ACMG/AMP-classified, tiered clinical reports, following GATK Best Practices.

    Illumina and MGI reads · GATK · ClinVar · ACMG/AMP · NVIDIA Parabricks where the science permits

  • Microbiome and metagenomics

    16S profiling, shotgun functional profiling, metagenome-assembled genomes, diversity and differential abundance.

    Short-read and Nanopore · versioned reference databases

  • Isolate genomics

    Bacterial whole-genome sequencing with AMR and MLST, fungal assembly, amplicon species identification.

    Assembly · annotation · resistance and typing databases pinned per run

  • Transcriptomics

    Bulk RNA-Seq expression analysis across short-read and Nanopore direct-RNA data.

    Alignment or pseudo-alignment · differential expression · QC at every step

  • Reproducible pipelines

    Containerised, version-pinned workflows: identical inputs give identical outputs, with the provenance to prove it.

    Nextflow · Docker · AWS Batch, Azure Batch or Google Cloud Batch · pinned references

  • Clinical interoperability

    ABDM-FHIR interoperability, NABL workflow alignment and DPDP-compliant handling of patient data.

    FHIR resources · tamper-evident audit trail · clinician sign-off before release

How we work with you

Start by validating one analysis on your samples.

  1. 014–8 weeks

    Pipeline validation

    One analysis built and validated on your samples against reference data, with QC thresholds agreed first.

    You leave with

    A validated pipeline and a report you can show an accreditation reviewer.

    Talk to a bioinformatician
  2. 0210–20 weeks

    Platform build

    Pipelines in production in your cloud account, with the sign-off workflow, provenance store and interoperability wired in.

    You leave with

    A genomics platform your lab runs and your auditor can replay.

  3. 03Ongoing

    Bioinformatics retainer

    Pipelines kept current with references and tools, new assays added, and a review every month.

    You leave with

    A bioinformatician on the platform, and a monthly record of what ran and how.

Five phases, and the artefact a clinical pipeline needs at each one.

The full process
  1. 01

    Discovery & Strategy

    1-2 weeks

    Assay and analysis scope, the sample-flow map, and the reference and database versions agreed in writing

    Signed off by you, before engineering starts

  2. 02

    Architecture & Design

    2-3 weeks

    Pipeline architecture with the QC and sign-off gates drawn in, reviewed with your quality lead

    Signed off by your security team

  3. 03

    Agile Development

    4-12 weeks

    Containerised pipelines with validation runs and the review trail

    Signed off by a senior engineer, every PR

  4. 04

    Quality Assurance

    2-4 weeks

    Validation report against reference samples and the agreed metrics

    Signed off by your QA and compliance teams

  5. 05

    Launch & Evolution

    Ongoing

    Run telemetry, the provenance store and a monthly pipeline review

    Signed off by your team, every week

A build engagement runs 9-21 weeks to launch, then ongoing. Every phase ends with a named artefact and a named sign-off, under ISO/IEC 27001 and ISO 9001 controls.

Recent work on this line

Three engagements on this line now.

  • Life Sciences / Biotechnology

    Active engagement

    Bioinformatics and AI-driven workflow engineering for an Indian biotech firm

    • Biotech
    • AI workflows
    • Platform engineering
  • Healthcare / Genomics

    Active engagement

    Genomics-domain platform for an Indian clinical genomics centre

    • Clinical genomics
    • Clinical workflow
    • Platform
  • Life Sciences

    In active development

    InferaGen.ai: eight analyses built across three pipeline families

    • WES + ACMG
    • Metagenomics
    • RNA-Seq

How we work

Built like a product company, shipped like one.

  1. 01

    Audit-engineered by default

    Every engagement runs under ISO/IEC 27001, ISO 9001, ISO/IEC 20000, and ISO/IEC 42001 controls. DPDP-aligned, with HIPAA / GDPR / RBI overlays available per project.

  2. 02

    Founder-led delivery

    Your discovery call is with a founder. The architecture review is with a senior engineer who stays on the project. No body-shop, no offshore handoff, no account-manager translation layer.

  3. 03

    Bias to ship, not slide

    We don't write demos that can't survive a Friday production deploy. Every milestone produces an artifact your team can use immediately: code, diagrams, telemetry.

Questions buyers ask

Straight answers, before the first call.

Which sequencing platforms and assays do you support?
Short-read data from Illumina and MGI and long-read data from Oxford Nanopore. Built today: whole-exome secondary analysis with ACMG/AMP classification, 16S and shotgun metagenomics with metagenome-assembled genomes, bacterial and fungal isolate genomics, and bulk RNA-Seq. Wider clinical, research and epigenomics scope is in development, and we say which is which.
Is the pipeline reproducible enough for an accreditation audit?
That is what it is built for. Every run is containerised and version-pinned, with the tool versions, reference genome and database versions recorded per sample, so identical inputs give identical outputs and any run can be replayed. The validation report is written against the metrics your quality lead names, in the form a NABL assessor expects.
Can patient data stay in India?
Yes. Pipelines run in your own AWS, Azure or Google Cloud account in an India region, with personal data handled under the DPDP Act and the audit trail kept in-region alongside it.
Do you provide the clinical interpretation, or only the pipeline?
The pipeline, the annotation and a draft classification with its evidence assembled per variant. A clinician signs before a report exists; we build the sign-off gate, we do not stand in it. The report is tiered, NABL-aligned and exportable as FHIR.
How is this related to InferaGen.ai?
Same team, same pipelines. InferaGen.ai is the clinical genomics platform we are building ourselves, in active development, with eight analyses built across three pipeline families. Client work on this line uses the same engineering and the same provenance discipline, in the client's own account.

Have a genomics or multi-omics workflow to build?

Book a 30-minute call with the team building the pipelines. We'll review your assays and tell you what a validated pipeline would take.

+91 912-195-7728Hyderabad, IndiaEvery brief gets a senior review. Reply within 1 business hour, 9 AM-7 PM IST.